Postoperative or Post-Traumatic Infections DRG 857 Reimbursement

DRG 857 covers postoperative or post-traumatic infections requiring operating room procedures and coded with a Complication or Comorbidity. It matters for inpatient reimbursement because the operating room procedure plus the documented Complication or Comorbidity increases resource use and influences Medicare payment under the inpatient prospective payment system.

DRG 857 Overview

DRG 857 covers inpatient encounters for postoperative or post-traumatic infections that required an operating room procedure and are coded with a Complication or Comorbidity. These cases typically involve surgical debridement, drainage, or revision procedures for wound infections, hardware-related infections, or abscesses following trauma or prior surgery. This Diagnosis-Related Group is relevant to Medicare payment because the presence of a Complication or Comorbidity increases resource intensity compared with cases without such comorbid conditions, influencing Hospital reimbursement under the inpatient prospective payment system. Accurate documentation and coding of the infection, associated procedures, and comorbid conditions determine assignment to DRG 857 and the resulting payment weight.

Acute surgical intervention and antimicrobial timing trials: randomized or prospective cohort studies assessing the impact of different intraoperative source-control strategies (for example, extent of debridement, use of negative-pressure wound therapy adjuncts, or timing of reoperation) and the timing and route of empirical antibiotics in patients presenting with postoperative or post‑traumatic infections requiring OR procedures. These studies enroll adult and sometimes pediatric inpatients who require operative management for wound, soft-tissue, or deep surgical-site infections and aim to identify approaches that reduce ongoing sepsis, need for additional operations, and length of stay. Results inform surgeons and hospital payers about interventions that can shorten ICU/hospital days and reduce readmissions and resource utilization.
Comparative effectiveness and antibiotic stewardship studies: pragmatic trials or observational comparative-effectiveness research comparing shorter versus standard durations of systemic antimicrobial therapy, oral step-down strategies after source control, or institution-level stewardship bundles in patients with complicated postoperative or post‑traumatic infections that had operative management. These studies focus on heterogeneous hospital populations, including those with comorbidities or device-related infections, to evaluate clinical cure, adverse events, antimicrobial resistance emergence, and total inpatient costs. Findings are directly relevant to providers and payers because optimized antibiotic use can lower medication costs, decrease adverse event–related expenditures, and impact quality metrics and reimbursement tied to antimicrobial stewardship.
Post-discharge outcomes and care-transition studies: prospective cohort studies and care‑coordination interventions that follow patients after discharge from hospital for surgical-site infections treated with OR procedures, examining readmission rates, wound-healing trajectories, outpatient intravenous antibiotic needs, home health utilization, and patient-reported outcomes. The population includes patients with complicated postoperative or traumatic wound infections who may require prolonged outpatient care or device management (eg, drains, wound VACs); studies evaluate which discharge planning, telehealth follow‑up, or outpatient infusion models reduce rehospitalization and overall cost. This research helps hospitals and payers identify effective post-acute care pathways that improve outcomes while minimizing readmissions and high-cost inpatient care.

Acute surgical intervention and antimicrobial timing trials: randomized or prospective cohort studies assessing the impact of different intraoperative source-control strategies (for example, extent of debridement, use of negative-pressure wound therapy adjuncts, or timing of reoperation) and the timing and route of empirical antibiotics in patients presenting with postoperative or post‑traumatic infections requiring OR procedures. These studies enroll adult and sometimes pediatric inpatients who require operative management for wound, soft-tissue, or deep surgical-site infections and aim to identify approaches that reduce ongoing sepsis, need for additional operations, and length of stay. Results inform surgeons and hospital payers about interventions that can shorten ICU/hospital days and reduce readmissions and resource utilization.
Comparative effectiveness and antibiotic stewardship studies: pragmatic trials or observational comparative-effectiveness research comparing shorter versus standard durations of systemic antimicrobial therapy, oral step-down strategies after source control, or institution-level stewardship bundles in patients with complicated postoperative or post‑traumatic infections that had operative management. These studies focus on heterogeneous hospital populations, including those with comorbidities or device-related infections, to evaluate clinical cure, adverse events, antimicrobial resistance emergence, and total inpatient costs. Findings are directly relevant to providers and payers because optimized antibiotic use can lower medication costs, decrease adverse event–related expenditures, and impact quality metrics and reimbursement tied to antimicrobial stewardship.
Post-discharge outcomes and care-transition studies: prospective cohort studies and care‑coordination interventions that follow patients after discharge from hospital for surgical-site infections treated with OR procedures, examining readmission rates, wound-healing trajectories, outpatient intravenous antibiotic needs, home health utilization, and patient-reported outcomes. The population includes patients with complicated postoperative or traumatic wound infections who may require prolonged outpatient care or device management (eg, drains, wound VACs); studies evaluate which discharge planning, telehealth follow‑up, or outpatient infusion models reduce rehospitalization and overall cost. This research helps hospitals and payers identify effective post-acute care pathways that improve outcomes while minimizing readmissions and high-cost inpatient care.

OpenPayer

Summary & Overview

Postoperative or Post-Traumatic Infections with O.R. Procedures with CC: Inpatient Reimbursement Overview

DRG 857 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes